![美股異動:蘋果盤前漲0.7% 年內漲幅超32% 終止“先買後付”服務](https://i-invdn-com.investing.com/news/LYNXMPEA7306L_S.jpg)
注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Immix Biopharma Inc是一家臨床階段的生物製藥公司。該公司正在開發一類用於腫瘤學和炎症的組織特異性療法(TSTx)。該公司主要資產IMX-110正在美國和澳大利亞進行實體瘤的Ib/IIa期臨床試驗。 IMX-110是一種帶負電荷的TSTx,它同時通過一種多激酶抑製劑禁用耐藥途徑,並通過一種控制腫瘤微環境(TME)正常化技術的凋亡誘導劑誘導腫瘤細胞死亡。 IMX-110正在美國和澳大利亞進行實體瘤臨床試驗。該公司的System Multi-Action Regulators SMARxT Tissue-Specific平台生產的藥物在預期治療部位的積累速度是傳統藥物的三至五倍。其免疫正常化技術用於GLUT1抗體生物標誌物靶向結合多酚聚激酶抑製劑/凋亡誘導劑的炎症性腸病。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Magda Marquet | 63 | 2021 | Independent Director |
Gabriel Morris | 36 | 2021 | CFO & Director |
Sant Chawla | - | - | Member of Scientific Advisory Board |
Jane Melissa Buchan | 58 | 2021 | Independent Director |
Ilya Rachman | 50 | 2012 | Co-Founder, CEO & Chairman |
Heather Landau | - | 2023 | Member of Scientific Advisory Board |
Michaela Liedtke | - | 2023 | Member of Scientific Advisory Board |
Suzanne Lentzsch | - | 2023 | Member of Scientific Advisory Board |
Marko Radic | - | 2023 | Member of Scientific Advisory Board |
Vaishali Sanchorawala | - | - | Member of Scientific Advisory Board |
Helen C. Adams | 64 | 2021 | Lead Independent Director |
Yekaterina Chudnovsky | 38 | 2023 | Independent Director |
Gary J. Schiller | - | - | Member of Scientific Advisory Board |
George W. Sledge | 72 | - | Member of Scientific Advisory Board |
Razelle Kurzrock | - | - | Member of Scientific Advisory Board |
Larry Norton | 77 | - | Chair of Scientific Advisory Board |
Jason Hsu | 49 | 2013 | Independent Director |
Galit Lahav | - | 2021 | Member of Scientific Advisory Board |
Carey J. Ng | 45 | 2019 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核